Susquehanna International Group, LLP Arvinas, Inc. Transaction History

Susquehanna International Group, LLP

  • $560 Billion
  • Q3 2024

A detailed history of Susquehanna International Group, LLP transactions in Arvinas, Inc. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 8,400 shares of ARVN stock, worth $160,272. This represents 0.0% of its overall portfolio holdings.

Number of Shares
8,400
Previous 69,300 87.88%
Holding current value
$160,272
Previous $1.84 Million 88.83%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 07, 2024
SELL
$36.38 - $52.31 $739,132 - $1.06 Million
-20,317 Reduced 76.31%
6,308 $260,000
Q4 2023

Feb 14, 2024
BUY
$14.19 - $42.33 $103,757 - $309,516
7,312 Added 37.86%
26,625 $1.1 Million
Q3 2023

Nov 14, 2023
SELL
$19.64 - $28.21 $212,956 - $305,881
-10,843 Reduced 35.96%
19,313 $379,000
Q2 2023

Aug 11, 2023
SELL
$21.73 - $31.43 $316,367 - $457,589
-14,559 Reduced 32.56%
30,156 $748,000
Q1 2023

May 16, 2023
SELL
$26.15 - $37.26 $416,517 - $593,477
-15,928 Reduced 26.27%
44,715 $1.22 Million
Q4 2022

Feb 14, 2023
BUY
$32.47 - $57.24 $513,188 - $904,678
15,805 Added 35.25%
60,643 $2.07 Million
Q3 2022

Nov 14, 2022
BUY
$41.87 - $57.99 $1.88 Million - $2.6 Million
44,838 New
44,838 $2 Million
Q4 2021

Feb 14, 2022
BUY
$65.85 - $96.21 $76,649 - $111,988
1,164 Added 24.41%
5,933 $487,000
Q3 2021

Nov 15, 2021
SELL
$73.2 - $107.87 $542,412 - $799,316
-7,410 Reduced 60.84%
4,769 $392,000
Q1 2021

May 17, 2021
SELL
$58.19 - $91.37 $185,917 - $291,927
-3,195 Reduced 20.78%
12,179 $805,000
Q4 2020

Feb 16, 2021
SELL
$20.19 - $84.93 $614,724 - $2.59 Million
-30,447 Reduced 66.45%
15,374 $1.31 Million
Q3 2020

Nov 16, 2020
BUY
$22.99 - $36.34 $166,194 - $262,701
7,229 Added 18.73%
45,821 $1.08 Million
Q2 2020

Aug 14, 2020
SELL
$29.88 - $56.74 $1.05 Million - $2 Million
-35,239 Reduced 47.73%
38,592 $1.29 Million
Q1 2020

May 15, 2020
BUY
$33.0 - $54.5 $2.44 Million - $4.02 Million
73,831 New
73,831 $2.98 Million

Others Institutions Holding ARVN

# of Institutions
229
Shares Held
68.4M
Call Options Held
226K
Put Options Held
285K
View Full List

About ARVINAS, INC.

ARVN Quotes by TradingView
  • Ticker ARVN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 53,205,300
  • Market Cap $1.02B
  • Description
  • Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor ...
More about ARVN
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email